Therapeutic Asset Ratings
13,157 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
MELPHALAN
Lymphoblastic Lymphoma
Masonic Cancer Center, University of Minnesota
P2
B
(63)
MERCAPTOPURINE ANHYDROUS
Glioblastoma
The First Affiliated Hospital with Nanjing Medical University
P2
B
(63)
Metformin
Pancreatic Adenocarcinoma
City of Hope Medical Center
P2
B
(63)
METHOTREXATE
Follicular Lymphoma
University of Michigan Rogel Cancer Center
P2
B
(63)
METHOTREXATE
Sickle Cell Disease
City of Hope Medical Center
P2
B
(63)
Midostaurin
Acute Myeloid Leukemia By FAB Classification
Mayo Clinic
P2
B
(63)
MITOMYCIN C
Appendix Cancer
National Cancer Institute (NCI)
P2
B
(63)
MITOMYCIN C
Gastric Cancer
City of Hope Medical Center
P2
B
(63)
MITOMYCIN C
Peritoneal Mesothelioma
National Cancer Institute (NCI)
P2
B
(63)
Mitoxantrone
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer Center
P2
B
(63)
Montanide Isa 51
Lung Cancer
Roswell Park Cancer Institute
P2
B
(63)
Nivolumab
Castration-Resistant Prostate Carcinoma
Rana McKay, MD
P2
B
(63)
Nivolumab
Colorectal Adenocarcinoma
University Hospital, Akershus
P2
B
(63)
Nivolumab
Colorectal Carcinoma
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(63)
Nivolumab
Her2-Receptor Negative Breast Cancer
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Ovarian Serous Adenocarcinoma
pharmaand GmbH
P2
B
(63)
Nivolumab
Lung Carcinoma
M.D. Anderson Cancer Center
P2
B
(63)
Nivolumab
Metastatic Neoplasm
Mohammed Milhem
P2
B
(63)
Nivolumab
Skin Basal Cell Carcinoma
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Rectum Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(63)
Nivolumab
Skin Squamous Cell Carcinoma
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Pancreatic Neoplasm
Orion Corporation, Orion Pharma
P2
B
(63)
Nivolumab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
University of Michigan Rogel Cancer Center
P2
B
(63)
Nivolumab
B-Cell Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris
P2
B
(63)
Showing 1026 to 1050 of 13,157 assets
Previous
Page 42 of 527
Next